Ovarian cancer care costs are likely to increase as newer, more effective, but expensive treatment regimens become available. According to researchers, women with endometriosis had a 4.2x higher ovarian cancer risk than those without endometriosis. The study revealed that the use of genital talc increases ovarian cancer risk, particularly women who used talc frequently. The study suggests that current ultrasound screening protocols might not be as accurate for Black patients "Genetic testing is rapidly evolving. Every six months there are different guidelines about who should get tested." Clinical data shows a 50-75% improvement in 5-year survival when cancers are detected at their earliest stages. Research has shown a troubling correlation between the use of hair relaxers and increased risk of certain cancers in women. Living in a more walkable neighborhood may protect women against the risk of obesity-related cancers The study highlights the importance of measuring estrone in postmenopausal women to determine cancer risk. CerMe may help detect women at a higher risk of contracting human papillomavirus (HPV). Studies have shown that Black and White women develop endometrial carcinoma at similar rates. Vaccines have been developed that significantly reduce the incidence of cervical cancer. The strong Black woman stereotype is detrimental to the well-being of Black patients with breast and ovarian cancers. Women with disabilities encounter social and economic barriers to reproductive health care and cervical cancer screening. Uterine cancer, also called endometrial cancer, is women's fourth most common cancer. Endometrial cancer is the fourth most common cancer type in the United States. Aggressive end-of-life care is contrary to clinical guidelines for treating ovarian cancer. With the new technology comes the hope that cervical cancer diagnosis can improve in low- and middle-income nations. Black women were more likely than white women to undergo screening for cervical cancer, the study also showed. The analysis can inform the practice of providers overseeing the recommended treatment course of gynecologic cancer patients.